Encuesta de la situación de la atención farmacéutica en el paciente con VIH en España

Barrueta, O. Ibarra; Valín, L. Ortega

doi:10.1016/s1130-6343(08)72836-8

Cited by 8 publications

(4 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, reports studied for this review indicated that pharmacists do offer services that enable measurement, monitoring, and improvement of patient adherence to medication therapy. These services include pill-organizers44, Medication Review with Follow-up services23-27,29, and hospital protocol programs aimed at detecting adherence problems 45…”

Section: Resultsmentioning

confidence: 99%

Adherence: a review of education, research, practice and policy in Spain

Aslani

Krass

2009

Pharmacy Practice (Internet)

View full text Add to dashboard Cite

Aims:To describe medication adherence education, practice, research and policy efforts carried out by pharmacists in Spain in the last decade.Methods:A literature review using Medline and Embase was conducted covering the last ten years. Additional pharmaceutical bibliographic sources in Spain were consulted to retrieve articles of interest from the last decade. Articles were included if a pharmacist was involved and if medication adherence was measured or there was any direct or indirect pharmacist intervention in monitoring and/or improving adherence. Articles focusing on the development of tools for adherence assessment were collected. Pre- and post-graduate pharmacy training programs were also reviewed through the Spanish Ministry of Education and Science website. Information regarding policy issues was gathered from the Spanish and Autonomous Communities of Education and Health Ministries websites.Results:Pharmacists receive no specific training focused on adherence. There is no specific government policies for pharmacists in Spain related to medication adherence regardless of their practice setting. A total of 24 research studies met our inclusion criteria. Of these, 10 involved pharmacist intervention in monitoring and/or improving adherence and 14 assessed only adherence. Ten studies involved hospital pharmacists working in collaboration with another healthcare professional.Conclusions:At present in Spain, the investigative role of the pharmacist is not well developed in the area of medication adherence. Adherence improvement services provided to patients by pharmacists are not implemented in a systematic way. However, recent efforts to implement new initiatives in this area may provide the basis for offering new cognitive services aimed at improving patient adherence in the near future.

show abstract

Section: Resultsmentioning

confidence: 99%

Adherence: a review of education, research, practice and policy in Spain

Aslani

Krass

2009

Pharmacy Practice (Internet)

View full text Add to dashboard Cite

show abstract

“…A symptom was considered to be present if it has >2 points. The Spanish validated questionnaire was used (Ibarra-Barrueta et al, 2019).…”

Section: Methodsmentioning

confidence: 99%

HIV-positive women have higher prevalence of comorbidities and anticholinergic burden: assessment of the HIV-positive population from Menorca (Balearic Islands)

et al. 2022

View full text Add to dashboard Cite

Currently, the management of comorbidities and polypharmacy in HIV-infected patients requires a coordinated action, with special focus on gender differences. Observational, cross-sectional study was conducted to study the HIV population from Menorca (Illes Balears). Adult HIV-positive individuals on antiretroviral treatment attending the pharmacy service from Hospital Mateu Orfila (Menorca) were included. In a single visit, demographical and clinical characteristics, comorbidities and cotreatments were collected. Anticholinergic burden (Drug Burden Index, DBI), drug-to-drug interactions (BOT PLUS database) and symptoms associated with HIV treatment (HIV-SI index) were assessed. A total of 223 patients were included, 68.2% men, with a median age of 53.00 (44.50-58.00) years, median BMI of 24.07, 47.73% smokers and 9.90% drug consumers. Women had more advanced stages of the disease and significantly more symptoms (cough and anxiety) versus men (p = .033 and p = .048, respectively). Moreover higher exposures to anticholinergic drugs (DBI 0.51 vs. 0.27) were reported, together with more frequency of drug-to-drug interactions (57.7% vs. 37.5%; p = .005) that increased with age. Red interactions were more frequently reported in PI (2.69%), NNRTIs (1.92%) and booster drugs (1.92%). These results support the need to implement specific measures for the management of HIV-infected women and tools to assess polypharmacy and risk of drug-to-drug interactions.

show abstract

“…Este me ´todo presenta la ventaja de poder utilizarse en situaciones donde la recogida de medicacio ´n esta ´centralizada en una u ´nica farmacia, como ocurre en Espan ˜a donde se recoge la medicacio ´n en los Servicios de Farmacia de los hospitales que atienden al paciente. En una encuesta realizada en 68 hospitales espan ˜oles, el RDF era el me ´todo ma ´s utilizado como medida de adherencia 20 ; adema ´s este me ´todo ha sido utilizado en diferentes estudios en poblacio ´n VIH 21,22 .…”

Section: Discusio ´Nunclassified